FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076972 [Registered on: 18/11/2024] Trial Registered Prospectively
Last Modified On: 14/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   to evaluate the effect of Mustadi vati in Stanapeeda with respect to Breast Engorgement in Sutika avastha. 
Scientific Title of Study   Single arm, open label clinical study to evaluate the effect of Mustadi vati in Stanapeeda with respect to Breast Engorgement in Sutika avastha. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Priyanka Tekriwal 
Designation  MS Scholar 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  Prasuti tantra and streerog department, sumatibhai shah ayurved mahavidyalya, Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra
Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra 411028
Pune
MAHARASHTRA
411028
India 
Phone  8169315651  
Fax    
Email  priyankatekriwal98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kalpana B . Ayare 
Designation  MS prasuti tantra and streerog 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  Prasuti tantra and streerog department, sumatibhai shah ayurved mahavidyalya, Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra
Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra 411028
Pune
MAHARASHTRA
411028
India 
Phone  9423295630  
Fax    
Email  drkalpanaayare@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Priyanka Tekriwal 
Designation  MS Scholar 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  Prasuti tantra and streerog department, sumatibhai shah ayurved mahavidyalya, Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra 411028
Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra 411028
Pune
MAHARASHTRA
411028
India 
Phone  8169315651  
Fax    
Email  priyankatekriwal98@gmail.com  
 
Source of Monetary or Material Support  
Prasuti tantra and streerog department, sumatibhai shah ayurved mahavidyalya, Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra ,India,411028 
 
Primary Sponsor  
Name  Sumatibhai Shah Ayurved Mahavidyalya 
Address  Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra 411028 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka Tekriwal  Sumatibhai Shah Ayurved Mahavidyala  Prasuti tantra and streerog department, sumatibhai shah ayurved mahavidyalya, Survey No. 165-A, Tupe Patil Rd, Malwadi, Hadapsar, Pune, Maharashtra 411028
Pune
MAHARASHTRA 
8169315651

priyankatekriwal98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O922||Other and unspecified disorders ofbreast associated with pregnancy and the puerperium. Ayurveda Condition: STANYAVAHA-SROTODUSHTI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Mustadi vati, Reference: Sushrut, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 5 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Purpureal women after vaginal or caesarean section diagnosed with Stanapeeda with respect to Breast Engorgement. 
 
ExclusionCriteria 
Details  Breast abscess
- Breast wound eg. Crack nipples.
- Breast Fibroadenoma
- Mastitis.
- CA Breast and other skin lesions or disease 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of Mustadi vati 500mg TDS for consecutive 5days in Stanapeeda with respect to Breast Engorgement.  For consecutive 5 days. 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the effect of Mustadi vati 500mg TDS for consecutive 5days in Stanapeeda with respect to Breast Engorgement.  For consecutive 5 days 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Breast Engorgement is stated as enlarged and filling of the breasts with milk. It  is the physiologic condition characterized by the painful swelling of the breasts associated with sudden increase in milk volume, lymphatic and vascular congestion and interstitial edema during the first two weeks following birth. It is associated with hard, painful, throbbing, aching, and tender breasts which may result in women needing analgesia, developing mastitis which may lead to temporarily or permanently stopping breastfeeding 
Close